Canadian investment bank Canaccord Genuity has reiterated its 'Buy' rating on LightPath Technologies, a US-based specialist in infrared optics and photonics, pointing to the company's increasing emphasis on defence contracts as a catalyst for future growth. The reaffirmation comes as defence budgets across NATO nations, including the UK, continue to rise in response to geopolitical tensions.
LightPath, which supplies optical components for thermal imaging, targeting systems, and missile warning sensors, has been pivoting its product portfolio towards higher-margin defence programmes. Canaccord analysts noted that the company's recent contract wins and pipeline visibility support a positive outlook, even as broader technology markets face headwinds from higher interest rates.
For UK investors, the defence technology theme has gained traction as the government pledged to increase defence spending to 2.5% of GDP by 2027. Companies along the supply chain, from prime contractors to niche component makers, are seen as beneficiaries of this multi-year spending cycle. LightPath's UK exposure is limited, but its technology is used in systems operated by British armed forces.
The FTSE 100 edged up 0.3% on Monday to 8,245 points, with defence names such as BAE Systems rising 1.1% on the day. The wider Aerospace & Defence sector has outperformed the broader market this year, adding roughly 12% year-to-date, as institutional investors rotate into 'hardware-heavy' defence plays. Analysts caution, however, that valuations are elevated and earnings must deliver to justify current multiples.
Canaccord's price target for LightPath remains unchanged, though the firm did not disclose a specific figure. The bank's endorsement reflects a broader trend of analysts favouring companies with direct exposure to long-duration defence programmes, which offer revenue visibility and pricing power. UK pension funds with exposure to US small-cap equities may see indirect benefits if LightPath's order book expands.